InvestorsHub Logo
Followers 367
Posts 10707
Boards Moderated 0
Alias Born 04/19/2008

Re: stervc post# 62446

Monday, 06/26/2017 9:25:20 PM

Monday, June 26, 2017 9:25:20 PM

Post# of 100369
MedReleafs’ ties with Tikun Olam: 10% monthly growth

I would like to focus in on the section of the article referenced below related to MedReleaf [ https://medreleaf.com ] to identify a few growth points/similarities which I think could be possible for BLDV; time will tell.


1. Like other new medical marijuana producers, MedReleaf “started at zero,” Closner said. Today, he reckons it’s Canada’s largest company in the sector, based on revenue.

- Key words here are started at zero which is where BLDV started from.


2. Growth prospects are apparent. In addition to the company’s 55,000-square- foot headquarters, of which 30,000 square feet are reserved for plants, a 210,000-square-foot plant-growing facility is currently under construction. (Note: This is for MedReleaf extracted from the article below)

- Health Canada's website confirms that MedReleaf has two locations in Ontario, Canada. AMS's 50,000 sq. ft. warehouse is located in Hannover, Ontario, Canada.

Source: http://hc-sc.gc.ca/dhp-mps/marihuana/info/list-eng.php


3. Closner credits MedReleafs’ ties with Tikun Olam for helping spur growth, which he said is running at 10 per cent per month.

- Key here is Tikun Olam [ http://www.tikun-olam.info ] and how it helped MedReleaf spur its growth. Reading the text below about Tikun Olam I can potentially see why BLDV is going to Israel (i.e. seeds and technology).

About Us

Tikun Olam Ltd. is the first, largest and foremost supplier of medical Cannabis in Israel, and one of leading medical cannabis companies in the world.

Tikun Olam is the flag bearer and pioneer of the treatment of patients with medical cannabis in Israel. The company is privately held and has been operating under license from the Israel Ministry of Health since 2007.

With The most extensive patient treatment database in the world and clinical research, Tikun Olam provides safe and suitable treatment – from pediatric to geriatric patients. Tikun Olam breeds unique proprietary cannabis strains and develops standardized consistent products with accurate dosage. Tikun Olam is a vertically integrated company – from plant to patient, founder of the first in world professional cannabis Nursing Clinic.

Since 2014 Tikun Olam cooperates with Medreleaf of Canada, to treat Canadian patients. In 2016 Tikun Olam expanded its business to the US and established a subsidiary company Tikun Olam USA. In 2017 Tikun Olam announces cooperation with Medifarm of Australia, Queensland's first medicinal cannabis growing licence.

Source: http://www.tikun-olam.info/article.php?id=1013

- Similarly, if we look at the "About" description of MedReleaf, we see their focus on R&D and their ISO registration. Notice how the key is the sourcing which I presume is seed quality and technology, from Israel of course.

MedReleaf sets The Medical Grade Standard™ for cannabis in Canada and around the world. The first and only ISO 9001 certified cannabis producer in North America, MedReleaf is a R&D-driven company dedicated to patient care, scientific innovation, research and advancing the understanding of the therapeutic benefits of cannabis. Sourced from around the world and perfected in one of two state of the art facilities in Ontario, MedReleaf delivers a variety of premium products to patients seeking safe, consistent and effective medical cannabis.

Source: https://medreleaf.com/about


4. Looking at the home page of Tikun Olam, you will see MedReleaf displayed on their homepage for the partnership they have in Canada. Also, notice the media coverage references at the bottom of their homepage:

http://www.tikun-olam.info/

- Here is a CNN news clip titled 'Israel's next export: Kosher cannabis?' published on March 7, 2016:



The news clip mentions Tikun Olam at 1:36. At 2:00 in the news clip, the CEO of Tikun Olam, Aharon Lutzky, describes the potential for exporting oils and cannabis export business could be in the hundreds of millions of dollars.

Time will tell, whether similar to MedReleaf, to what extent BLDV and AMS will be developing such strategic and beneficial exporting partnerships in Israel to spur the growth of AMS.

If anyone has any thoughts or comments, please share them.

Go BLDV!

Referenced Article: http://www.cjnews.com/news/canada/for-canada-and-israels-marijuana-industries-a-budding-partnership

Buy cautiously and sell reluctantly. All of my posts are In My Opinion only based on the DD I have completed. Please do your own DD and make your own decisions.